AI assistant
Sending…
ImmunityBio, Inc. — Director's Dealing 2015
Dec 12, 2015
31529_dirs_2015-12-11_3315c4ad-d675-4fa4-a328-38257baa8730.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-12-10
Reporting Person: Wilson Angela (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-10 | Common Stock | P | 167 | $15.28 | Acquired | 167 | Direct |
| 2015-12-10 | Common Stock | P | 76 | $15.31 | Acquired | 243 | Direct |
| 2015-12-10 | Common Stock | P | 3022 | $15.33 | Acquired | 3265 | Direct |
More from ImmunityBio, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24